KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baker Hughes (BKR) Asset Writedowns and Impairment (2019 - 2024)

Historic Asset Writedowns and Impairment for Baker Hughes (BKR) over the last 6 years, with Q4 2024 value amounting to $77.0 million.

  • Baker Hughes' Asset Writedowns and Impairment rose 32647.06% to $77.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $77.0 million, marking a year-over-year increase of 780000.0%. This contributed to the annual value of $77.0 million for FY2024, which is 780000.0% up from last year.
  • As of Q4 2024, Baker Hughes' Asset Writedowns and Impairment stood at $77.0 million, which was up 32647.06% from -$34.0 million recorded in Q4 2023.
  • Baker Hughes' Asset Writedowns and Impairment's 5-year high stood at $725.0 million during Q1 2020, with a 5-year trough of -$260.0 million in Q4 2022.
  • Its 5-year average for Asset Writedowns and Impairment is $86.0 million, with a median of $17.0 million in 2020.
  • Data for Baker Hughes' Asset Writedowns and Impairment shows a peak YoY increase of 183636.36% (in 2022) and a maximum YoY decrease of 175714.29% (in 2022) over the last 5 years.
  • Baker Hughes' Asset Writedowns and Impairment (Quarter) stood at $42.0 million in 2020, then crashed by 133.33% to -$14.0 million in 2021, then crashed by 1757.14% to -$260.0 million in 2022, then surged by 86.92% to -$34.0 million in 2023, then skyrocketed by 326.47% to $77.0 million in 2024.
  • Its Asset Writedowns and Impairment stands at $77.0 million for Q4 2024, versus -$34.0 million for Q4 2023 and $15.0 million for Q2 2023.